Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2006;47:16-18
Published online before print December 12, 2005, doi: 10.1161/01.HYP.0000196730.13216.f3
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
47/1/16    most recent
01.HYP.0000196730.13216.f3v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Touyz, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Touyz, R. M.
Related Collections
Right arrow Cerebrovascular disease/stroke

(Hypertension. 2006;47:16.)
© 2006 American Heart Association, Inc.


Editorial Commentaries

Lipid Rafts Take Center Stage in Endothelial Cell Redox Signaling by Death Receptors

Rhian M. Touyz

From the Canada Research Chair in Hypertension, Kidney Research Centre, Ottawa Health Research Institute, University of Ottawa, Ontario, Canada.

Correspondence to Rhian M Touyz MD, PhD, Canada Research Chair in Hypertension, Ottawa Health Research Institute, University of Ottawa, 451 Smyth Rd, Ottawa, ON, KIH 8M5. E-mail: rtouyz@uottawa.ca


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Reactive oxygen species are important signaling molecules mediating diverse biological effects in vascular cells ranging from cell growth to cell death.1 The primary enzymatic source of vascular reactive species is the multisubunit NAD(P)H oxidase, expressed and functionally active in endothelial, vascular smooth muscle, and adventitial cells.2 Activation of G protein-coupled receptors by vasoactive agents, such as angiotensin II (Ang II), and receptor tyrosine kinases by growth factors, such as epidermal growth factor (EGF), stimulate NAD(P)H oxidase–derived generation of superoxide and hydrogen peroxide in vascular smooth muscle cells, which activate mitogen-activated protein kinase growth signaling pathways and promote cell cycle progression. In pathological conditions associated with vascular injury and remodeling, increased oxidative stress is now considered a fundamental factor underlying proliferation and hypertrophy of vascular smooth muscle cells.1,2 Paradoxically in endothelial cells, death receptor ligands and proapoptotic agonists, including tumor necrosis factor (TNF) {alpha}, Fas ligand (FasL), and endostatin, also stimulate NAD(P)H oxidase–mediated production of reactive oxygen species.3–5 These processes trigger endothelial cell apoptosis, anoikis, and impaired dilation. How then can agonists that promote cell growth and cell death trigger the same redox-sensitive pathways to elicit divergent cellular responses, and what are the mechanisms that link growth/death receptors to NAD(P)H oxidase in vascular cells?

Emerging evidence indicates that lipid microenvironments on the cell surface, known as lipid rafts, may be critically involved in distal redox-sensitive signaling events and ultimate cell fate.6,7 In vascular smooth muscle cells, Ang II–induced cell growth involves epidermal growth factor receptor (EGFR) transactivation, mediated through redox-sensitive c-Src, . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Jin, F. Yi, F. Zhang, J. L. Poklis, and P.-L. Li
Lysosomal Targeting and Trafficking of Acid Sphingomyelinase to Lipid Raft Platforms in Coronary Endothelial Cells
Arterioscler Thromb Vasc Biol, November 1, 2008; 28(11): 2056 - 2062.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
S. Sonnino, L. Mauri, V. Chigorno, and A. Prinetti
Gangliosides as components of lipid membrane domains
Glycobiology, January 1, 2007; 17(1): 1R - 13R.
[Abstract] [Full Text] [PDF]